As the industry is being overshadowed by political and legal risks shares in the health care industry might not be the defensive plays they used to, said CNN Business’ Paul La Monica on the digital series Markets Currently.

With President donaldtrump pushing lower drug prices and presidential candidate Elizabeth Warren supporting Bernie Sanders’ Medicare for many idea, there is plenty to fret about for healthcare businesses.

A case in point this week’s consumer care company Johnson & Johnson (JNJ), which has been arranged to pay $8 billion in compensation in a case between the promotion of its anti-psychotic drug Risperdal.